| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy in Diabetics | 18 | 2023 | 197 | 2.020 |
Why?
|
| Drug Labeling | 3 | 2017 | 248 | 1.340 |
Why?
|
| Drug Approval | 6 | 2020 | 814 | 1.200 |
Why?
|
| Informed Consent | 4 | 2020 | 1008 | 1.090 |
Why?
|
| Fetal Diseases | 20 | 2016 | 913 | 1.090 |
Why?
|
| Pregnancy | 108 | 2023 | 29862 | 1.080 |
Why?
|
| Pregnancy Outcome | 18 | 2022 | 2920 | 1.000 |
Why?
|
| United States Food and Drug Administration | 9 | 2020 | 1664 | 0.980 |
Why?
|
| Pregnancy Complications | 11 | 2022 | 2947 | 0.970 |
Why?
|
| Trisomy | 4 | 2014 | 260 | 0.940 |
Why?
|
| Diabetes, Gestational | 6 | 2023 | 1248 | 0.880 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2022 | 518 | 0.860 |
Why?
|
| Prenatal Diagnosis | 15 | 2014 | 1265 | 0.830 |
Why?
|
| Abortifacient Agents, Steroidal | 2 | 2016 | 22 | 0.800 |
Why?
|
| Labor, Induced | 3 | 2018 | 151 | 0.750 |
Why?
|
| Cesarean Section | 11 | 2017 | 1396 | 0.740 |
Why?
|
| Mifepristone | 2 | 2016 | 151 | 0.740 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2015 | 410 | 0.730 |
Why?
|
| Abortion, Spontaneous | 5 | 2019 | 533 | 0.710 |
Why?
|
| Contraception, Postcoital | 2 | 2011 | 20 | 0.690 |
Why?
|
| Abortion, Threatened | 1 | 2019 | 4 | 0.670 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 2023 | 0.650 |
Why?
|
| Abortion, Legal | 4 | 2015 | 114 | 0.640 |
Why?
|
| Progestins | 1 | 2020 | 301 | 0.620 |
Why?
|
| Pregnancy Complications, Neoplastic | 3 | 2017 | 258 | 0.610 |
Why?
|
| Choice Behavior | 2 | 2018 | 824 | 0.600 |
Why?
|
| Perinatal Mortality | 2 | 2015 | 101 | 0.580 |
Why?
|
| Cesarean Section, Repeat | 2 | 2009 | 28 | 0.560 |
Why?
|
| Congenital Abnormalities | 9 | 2010 | 709 | 0.550 |
Why?
|
| Delivery, Obstetric | 4 | 2021 | 940 | 0.510 |
Why?
|
| Home Childbirth | 1 | 2015 | 55 | 0.500 |
Why?
|
| Anesthetics, General | 1 | 2017 | 151 | 0.500 |
Why?
|
| Pre-Eclampsia | 5 | 2017 | 1231 | 0.490 |
Why?
|
| Physical Examination | 3 | 2020 | 1254 | 0.490 |
Why?
|
| Chromosome Disorders | 5 | 2013 | 499 | 0.470 |
Why?
|
| Government Regulation | 2 | 2016 | 524 | 0.460 |
Why?
|
| Anesthesia, General | 3 | 2020 | 1174 | 0.460 |
Why?
|
| Ribavirin | 4 | 2022 | 395 | 0.450 |
Why?
|
| Hyperglycemia | 1 | 2022 | 1376 | 0.450 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2017 | 2509 | 0.440 |
Why?
|
| Retinopathy of Prematurity | 2 | 2015 | 439 | 0.430 |
Why?
|
| Lactation | 1 | 2015 | 397 | 0.430 |
Why?
|
| Uterine Rupture | 2 | 2004 | 65 | 0.420 |
Why?
|
| Oxygen | 2 | 2015 | 4228 | 0.410 |
Why?
|
| Human Experimentation | 1 | 2013 | 123 | 0.410 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2004 | 61 | 0.410 |
Why?
|
| Obstetrics | 3 | 2017 | 665 | 0.400 |
Why?
|
| Blood Glucose | 8 | 2022 | 6391 | 0.400 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2014 | 339 | 0.380 |
Why?
|
| Diethylstilbestrol | 1 | 2011 | 87 | 0.370 |
Why?
|
| Midwifery | 1 | 2012 | 124 | 0.370 |
Why?
|
| Pregnant Women | 1 | 2015 | 566 | 0.360 |
Why?
|
| Vaginal Neoplasms | 1 | 2011 | 104 | 0.360 |
Why?
|
| Nonprescription Drugs | 3 | 2008 | 118 | 0.360 |
Why?
|
| Fetus | 6 | 2014 | 1864 | 0.350 |
Why?
|
| Female | 116 | 2023 | 392581 | 0.350 |
Why?
|
| Infant, Premature, Diseases | 2 | 2015 | 710 | 0.340 |
Why?
|
| Fetal Therapies | 1 | 2011 | 101 | 0.340 |
Why?
|
| Premature Birth | 2 | 2020 | 1782 | 0.330 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2011 | 217 | 0.330 |
Why?
|
| Meningomyelocele | 2 | 2011 | 171 | 0.330 |
Why?
|
| Anesthesia | 1 | 2020 | 1594 | 0.330 |
Why?
|
| Drug Industry | 1 | 2015 | 788 | 0.320 |
Why?
|
| Contraceptives, Postcoital | 2 | 2005 | 14 | 0.320 |
Why?
|
| Education, Medical | 1 | 2020 | 1725 | 0.310 |
Why?
|
| Radiotherapy | 1 | 2015 | 1499 | 0.310 |
Why?
|
| Contraceptives, Oral, Synthetic | 1 | 2008 | 16 | 0.310 |
Why?
|
| Prescription Drugs | 1 | 2015 | 631 | 0.300 |
Why?
|
| Endocrine Disruptors | 1 | 2011 | 264 | 0.300 |
Why?
|
| Levonorgestrel | 1 | 2008 | 74 | 0.290 |
Why?
|
| Politics | 3 | 2011 | 815 | 0.290 |
Why?
|
| Fetal Blood | 11 | 2008 | 1347 | 0.280 |
Why?
|
| Women's Rights | 1 | 2007 | 65 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2000 | 3441 | 0.270 |
Why?
|
| SAIDS Vaccines | 3 | 1999 | 145 | 0.270 |
Why?
|
| Asphyxia | 1 | 2006 | 60 | 0.270 |
Why?
|
| Clostridium sordellii | 1 | 2005 | 3 | 0.270 |
Why?
|
| Humans | 122 | 2023 | 761423 | 0.260 |
Why?
|
| Obstetric Labor, Premature | 3 | 2003 | 272 | 0.260 |
Why?
|
| Legislation, Drug | 1 | 2008 | 214 | 0.250 |
Why?
|
| Aspirin | 1 | 2017 | 3134 | 0.250 |
Why?
|
| Down Syndrome | 1 | 2014 | 901 | 0.250 |
Why?
|
| Supreme Court Decisions | 1 | 2007 | 133 | 0.250 |
Why?
|
| Personal Autonomy | 1 | 2008 | 304 | 0.250 |
Why?
|
| Labor, Obstetric | 3 | 2001 | 323 | 0.250 |
Why?
|
| Pregnancy Trimester, First | 5 | 2023 | 907 | 0.230 |
Why?
|
| Abortion, Therapeutic | 1 | 2004 | 35 | 0.230 |
Why?
|
| Fetal Death | 5 | 2009 | 435 | 0.230 |
Why?
|
| Clinical Trials as Topic | 3 | 2020 | 8000 | 0.230 |
Why?
|
| United States | 25 | 2021 | 72339 | 0.230 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 3081 | 0.220 |
Why?
|
| Child Development | 1 | 2015 | 2305 | 0.220 |
Why?
|
| Abortion, Induced | 3 | 2008 | 462 | 0.220 |
Why?
|
| Progesterone Congeners | 1 | 2003 | 44 | 0.220 |
Why?
|
| Hydroxyprogesterones | 1 | 2003 | 24 | 0.220 |
Why?
|
| Oximetry | 1 | 2006 | 460 | 0.220 |
Why?
|
| DNA | 3 | 2013 | 7219 | 0.220 |
Why?
|
| Teratogens | 3 | 2022 | 117 | 0.210 |
Why?
|
| Insulin | 7 | 2008 | 6602 | 0.210 |
Why?
|
| Magnesium Sulfate | 1 | 2003 | 73 | 0.210 |
Why?
|
| Heart | 1 | 2015 | 4405 | 0.200 |
Why?
|
| Amniotic Fluid | 6 | 2000 | 378 | 0.200 |
Why?
|
| Breech Presentation | 1 | 2002 | 39 | 0.200 |
Why?
|
| Genetic Testing | 2 | 2014 | 3538 | 0.200 |
Why?
|
| Private Sector | 1 | 2005 | 398 | 0.200 |
Why?
|
| Infant, Newborn | 29 | 2017 | 26212 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3639 | 0.190 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2023 | 731 | 0.190 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 3 | 2009 | 233 | 0.190 |
Why?
|
| Microcephaly | 2 | 2016 | 425 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2008 | 884 | 0.180 |
Why?
|
| Gynecological Examination | 1 | 2020 | 30 | 0.180 |
Why?
|
| Metformin | 1 | 2008 | 906 | 0.180 |
Why?
|
| Glyburide | 1 | 2000 | 116 | 0.170 |
Why?
|
| Parathyroid Neoplasms | 2 | 2011 | 242 | 0.170 |
Why?
|
| Fetal Organ Maturity | 5 | 2009 | 83 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2021 | 2152 | 0.170 |
Why?
|
| Biological Specimen Banks | 1 | 2005 | 783 | 0.170 |
Why?
|
| Pulmonary Surfactants | 2 | 2000 | 162 | 0.160 |
Why?
|
| Health Policy | 1 | 2011 | 2684 | 0.160 |
Why?
|
| alpha-Fetoproteins | 2 | 1991 | 223 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2002 | 406 | 0.160 |
Why?
|
| Clostridium Infections | 1 | 2005 | 558 | 0.160 |
Why?
|
| Neural Crest | 1 | 2001 | 279 | 0.160 |
Why?
|
| Phosphatidylcholines | 2 | 2000 | 405 | 0.150 |
Why?
|
| Women's Health | 1 | 2008 | 2065 | 0.150 |
Why?
|
| Cognition | 1 | 2015 | 6986 | 0.150 |
Why?
|
| Gestational Age | 17 | 2009 | 3576 | 0.150 |
Why?
|
| Infant, Premature | 4 | 2002 | 2104 | 0.150 |
Why?
|
| History, 20th Century | 3 | 2012 | 2769 | 0.140 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2017 | 66 | 0.140 |
Why?
|
| Hospitalization | 2 | 2021 | 10718 | 0.140 |
Why?
|
| Anencephaly | 2 | 2007 | 20 | 0.140 |
Why?
|
| Gynecology | 1 | 2002 | 526 | 0.140 |
Why?
|
| Simian immunodeficiency virus | 4 | 1999 | 809 | 0.140 |
Why?
|
| Intelligence | 1 | 2002 | 924 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2002 | 1139 | 0.140 |
Why?
|
| Decidua | 1 | 1996 | 82 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10203 | 0.130 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2017 | 108 | 0.130 |
Why?
|
| Voluntary Health Agencies | 1 | 2015 | 38 | 0.130 |
Why?
|
| Drug Information Services | 1 | 2015 | 51 | 0.130 |
Why?
|
| Embryo Research | 1 | 2015 | 38 | 0.130 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1996 | 231 | 0.120 |
Why?
|
| Progesterone | 1 | 2019 | 742 | 0.120 |
Why?
|
| Fetal Macrosomia | 3 | 2005 | 141 | 0.120 |
Why?
|
| Mass Screening | 2 | 2023 | 5428 | 0.120 |
Why?
|
| Placenta, Retained | 1 | 2014 | 22 | 0.120 |
Why?
|
| Uterine Inertia | 1 | 2014 | 29 | 0.120 |
Why?
|
| Risk | 5 | 2013 | 9612 | 0.120 |
Why?
|
| Brain | 3 | 2017 | 27107 | 0.120 |
Why?
|
| Pancreatitis | 2 | 2011 | 1096 | 0.120 |
Why?
|
| Pregnancy, Multiple | 3 | 1994 | 215 | 0.110 |
Why?
|
| Ultrasonography | 12 | 1989 | 5970 | 0.110 |
Why?
|
| Therapeutic Equipoise | 1 | 2013 | 28 | 0.110 |
Why?
|
| Physician-Patient Relations | 3 | 2020 | 3249 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 247 | 0.110 |
Why?
|
| State Government | 1 | 2016 | 384 | 0.110 |
Why?
|
| Placenta | 1 | 2022 | 1708 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2003 | 1906 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 13637 | 0.100 |
Why?
|
| Physicians | 2 | 2008 | 4591 | 0.100 |
Why?
|
| Uterus | 1 | 1996 | 649 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2001 | 1755 | 0.100 |
Why?
|
| Vaccines, Attenuated | 4 | 1999 | 315 | 0.100 |
Why?
|
| Vaccines | 1 | 2021 | 837 | 0.100 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 1999 | 541 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2017 | 857 | 0.100 |
Why?
|
| AIDS Vaccines | 2 | 1995 | 896 | 0.100 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1351 | 0.100 |
Why?
|
| Risk Factors | 11 | 2020 | 74167 | 0.100 |
Why?
|
| Hypercalcemia | 2 | 2011 | 423 | 0.100 |
Why?
|
| Placenta Previa | 1 | 2012 | 122 | 0.090 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2015 | 452 | 0.090 |
Why?
|
| Adenoma | 2 | 2011 | 2160 | 0.090 |
Why?
|
| Postpartum Hemorrhage | 1 | 2014 | 271 | 0.090 |
Why?
|
| Menotropins | 1 | 1990 | 41 | 0.090 |
Why?
|
| Mullerian Ducts | 1 | 2011 | 203 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 694 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2012 | 720 | 0.090 |
Why?
|
| Fetal Monitoring | 2 | 2006 | 69 | 0.090 |
Why?
|
| Hyperparathyroidism | 1 | 2011 | 337 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 413 | 0.080 |
Why?
|
| Time | 1 | 2011 | 545 | 0.080 |
Why?
|
| Vasculitis | 1 | 2013 | 521 | 0.080 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2011 | 163 | 0.080 |
Why?
|
| Infant Mortality | 3 | 2004 | 759 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1852 | 0.080 |
Why?
|
| Lung | 4 | 2009 | 9995 | 0.080 |
Why?
|
| Critical Care | 1 | 2021 | 2697 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1703 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 5441 | 0.070 |
Why?
|
| Civil Rights | 1 | 2008 | 132 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2002 | 4330 | 0.070 |
Why?
|
| Chromosomes, Human, 13-15 | 2 | 1986 | 49 | 0.070 |
Why?
|
| Hemorrhage | 2 | 2019 | 3425 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2015 | 4014 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2002 | 9320 | 0.070 |
Why?
|
| Blood Banks | 1 | 2008 | 108 | 0.070 |
Why?
|
| Breast Feeding | 1 | 2015 | 1358 | 0.070 |
Why?
|
| Ovulation | 1 | 2008 | 181 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 1996 | 1525 | 0.070 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.070 |
Why?
|
| Heart Rate, Fetal | 1 | 2006 | 75 | 0.070 |
Why?
|
| Paternal Exposure | 1 | 2007 | 96 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2012 | 1567 | 0.070 |
Why?
|
| Hydranencephaly | 1 | 1985 | 5 | 0.070 |
Why?
|
| Hernia, Umbilical | 1 | 2007 | 102 | 0.070 |
Why?
|
| Globins | 4 | 1988 | 403 | 0.070 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2006 | 88 | 0.060 |
Why?
|
| Blood Donors | 1 | 2008 | 345 | 0.060 |
Why?
|
| Adult | 31 | 2021 | 221148 | 0.060 |
Why?
|
| Vagina | 1 | 2011 | 838 | 0.060 |
Why?
|
| Fetal Development | 1 | 2011 | 769 | 0.060 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2008 | 305 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2017 | 2751 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2017 | 3057 | 0.060 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2006 | 161 | 0.060 |
Why?
|
| Cushing Syndrome | 1 | 2006 | 241 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 2019 | 0.060 |
Why?
|
| Morals | 1 | 2008 | 289 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 3 | 1997 | 515 | 0.060 |
Why?
|
| Macaca | 2 | 1996 | 412 | 0.060 |
Why?
|
| Trial of Labor | 1 | 2004 | 81 | 0.060 |
Why?
|
| Calcium | 1 | 1997 | 5727 | 0.060 |
Why?
|
| Chromosome Aberrations | 3 | 1988 | 1771 | 0.060 |
Why?
|
| Autoimmune Diseases | 2 | 2013 | 2248 | 0.060 |
Why?
|
| Oligohydramnios | 2 | 2001 | 37 | 0.060 |
Why?
|
| Patient Selection | 1 | 2015 | 4244 | 0.050 |
Why?
|
| Rh Isoimmunization | 2 | 2017 | 24 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 4172 | 0.050 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1983 | 95 | 0.050 |
Why?
|
| History, 17th Century | 1 | 2003 | 108 | 0.050 |
Why?
|
| Craniosynostoses | 1 | 2007 | 412 | 0.050 |
Why?
|
| Maternal Mortality | 1 | 2005 | 302 | 0.050 |
Why?
|
| Cryopreservation | 1 | 2008 | 728 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2007 | 921 | 0.050 |
Why?
|
| Nifedipine | 1 | 2003 | 221 | 0.050 |
Why?
|
| Eclampsia | 1 | 2003 | 56 | 0.050 |
Why?
|
| History, 18th Century | 1 | 2003 | 207 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 2162 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 7956 | 0.050 |
Why?
|
| Neoplasms, Fibroepithelial | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 474 | 0.050 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1983 | 179 | 0.050 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1982 | 195 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 1996 | 2677 | 0.050 |
Why?
|
| Thrombophlebitis | 2 | 1996 | 289 | 0.050 |
Why?
|
| Infant | 3 | 2022 | 36205 | 0.050 |
Why?
|
| Registries | 2 | 2022 | 8223 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2001 | 398 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 2116 | 0.040 |
Why?
|
| Safety | 2 | 2014 | 1150 | 0.040 |
Why?
|
| Hydrocephalus | 2 | 1986 | 764 | 0.040 |
Why?
|
| Sepsis | 2 | 2009 | 2585 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4852 | 0.040 |
Why?
|
| Blood Transfusion, Intrauterine | 3 | 1988 | 28 | 0.040 |
Why?
|
| Albumins | 3 | 2000 | 575 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2001 | 449 | 0.040 |
Why?
|
| Sulfonylurea Compounds | 1 | 2000 | 219 | 0.040 |
Why?
|
| Erythroblastosis, Fetal | 3 | 1988 | 62 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 973 | 0.040 |
Why?
|
| Drug Prescriptions | 1 | 2008 | 1669 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2020 | 616 | 0.040 |
Why?
|
| Gene Deletion | 2 | 1996 | 2667 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 14664 | 0.040 |
Why?
|
| Urinary Bladder | 3 | 1993 | 1152 | 0.040 |
Why?
|
| Staining and Labeling | 2 | 1992 | 1084 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2008 | 2179 | 0.040 |
Why?
|
| Adolescent | 7 | 2017 | 88313 | 0.040 |
Why?
|
| Salpingectomy | 1 | 2017 | 45 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 1991 | 3234 | 0.040 |
Why?
|
| Research | 1 | 2005 | 1977 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2265 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2017 | 42254 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1600 | 0.030 |
Why?
|
| Genes, vpr | 1 | 1996 | 19 | 0.030 |
Why?
|
| Endometritis | 1 | 1996 | 49 | 0.030 |
Why?
|
| Glucose Tolerance Test | 2 | 1997 | 1179 | 0.030 |
Why?
|
| Genes, nef | 1 | 1996 | 52 | 0.030 |
Why?
|
| Hypertension | 3 | 2006 | 8542 | 0.030 |
Why?
|
| Blood Specimen Collection | 2 | 1988 | 238 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2002 | 1037 | 0.030 |
Why?
|
| Retroviruses, Simian | 1 | 1995 | 12 | 0.030 |
Why?
|
| Chorionic Villi | 1 | 1995 | 53 | 0.030 |
Why?
|
| Trust | 1 | 2020 | 530 | 0.030 |
Why?
|
| Forecasting | 2 | 2002 | 2928 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 909 | 0.030 |
Why?
|
| Abortion, Habitual | 1 | 1995 | 61 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 1999 | 627 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2017 | 614 | 0.030 |
Why?
|
| Incidence | 4 | 2001 | 21341 | 0.030 |
Why?
|
| Reproductive Techniques | 1 | 1994 | 41 | 0.030 |
Why?
|
| HIV Infections | 2 | 1999 | 17347 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2011 | 583 | 0.030 |
Why?
|
| Triplets | 2 | 1994 | 43 | 0.030 |
Why?
|
| Male | 18 | 2022 | 360736 | 0.030 |
Why?
|
| Educational Status | 1 | 2002 | 2520 | 0.030 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 488 | 0.030 |
Why?
|
| Child of Impaired Parents | 1 | 2017 | 460 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 2007 | 4696 | 0.030 |
Why?
|
| Genes | 2 | 1987 | 1844 | 0.030 |
Why?
|
| Placenta Diseases | 1 | 1995 | 199 | 0.030 |
Why?
|
| Ectromelia | 1 | 1993 | 28 | 0.030 |
Why?
|
| Hematoxylin | 1 | 1992 | 60 | 0.030 |
Why?
|
| Low Back Pain | 2 | 2011 | 984 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 1992 | 69 | 0.030 |
Why?
|
| Urethral Obstruction | 2 | 1993 | 55 | 0.030 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1992 | 81 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 64651 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 1996 | 367 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 1996 | 1371 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1994 | 351 | 0.030 |
Why?
|
| Animals | 11 | 2022 | 168441 | 0.020 |
Why?
|
| Edema | 2 | 1986 | 767 | 0.020 |
Why?
|
| Anthropometry | 2 | 1995 | 1349 | 0.020 |
Why?
|
| Microcirculation | 1 | 1996 | 1273 | 0.020 |
Why?
|
| Virulence | 1 | 1995 | 1302 | 0.020 |
Why?
|
| Arteries | 1 | 1996 | 1124 | 0.020 |
Why?
|
| Sweden | 1 | 2014 | 1379 | 0.020 |
Why?
|
| Kidney Diseases, Cystic | 1 | 1992 | 183 | 0.020 |
Why?
|
| Reference Standards | 1 | 1995 | 1004 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2013 | 463 | 0.020 |
Why?
|
| Abnormalities, Multiple | 2 | 2001 | 1424 | 0.020 |
Why?
|
| Quadruplets | 1 | 1990 | 9 | 0.020 |
Why?
|
| Virus Replication | 2 | 1995 | 2435 | 0.020 |
Why?
|
| Clomiphene | 1 | 1990 | 71 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 1994 | 575 | 0.020 |
Why?
|
| Abdominal Muscles | 1 | 1991 | 169 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 8179 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 1999 | 1286 | 0.020 |
Why?
|
| Polyhydramnios | 1 | 1989 | 41 | 0.020 |
Why?
|
| Coloring Agents | 1 | 1972 | 559 | 0.020 |
Why?
|
| South Dakota | 1 | 2008 | 32 | 0.020 |
Why?
|
| Models, Biological | 2 | 1996 | 9469 | 0.020 |
Why?
|
| Head | 1 | 1995 | 924 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2013 | 80582 | 0.020 |
Why?
|
| Reference Values | 1 | 1996 | 4921 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2001 | 2223 | 0.020 |
Why?
|
| Amniocentesis | 1 | 1988 | 115 | 0.020 |
Why?
|
| Autopsy | 1 | 1992 | 1007 | 0.020 |
Why?
|
| Reproductive Rights | 1 | 2008 | 31 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1999 | 2319 | 0.020 |
Why?
|
| Age Factors | 1 | 2005 | 18400 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2011 | 15650 | 0.020 |
Why?
|
| Infertility, Female | 1 | 1994 | 760 | 0.020 |
Why?
|
| Urologic Diseases | 1 | 1991 | 247 | 0.020 |
Why?
|
| Noonan Syndrome | 1 | 1989 | 120 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 1989 | 137 | 0.020 |
Why?
|
| Puerperal Disorders | 1 | 1991 | 299 | 0.020 |
Why?
|
| Vomiting | 1 | 2011 | 652 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2013 | 746 | 0.020 |
Why?
|
| Fetal Hemoglobin | 2 | 1988 | 345 | 0.020 |
Why?
|
| Gene Products, vpr | 2 | 1999 | 33 | 0.020 |
Why?
|
| Fetal Distress | 1 | 1987 | 39 | 0.020 |
Why?
|
| Gene Products, nef | 2 | 1999 | 100 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2021 | 5291 | 0.020 |
Why?
|
| Butyrates | 1 | 1987 | 169 | 0.020 |
Why?
|
| Birth Weight | 1 | 1995 | 2100 | 0.020 |
Why?
|
| Rats | 2 | 2001 | 23742 | 0.020 |
Why?
|
| Gigantism | 1 | 1986 | 15 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10498 | 0.020 |
Why?
|
| Maternal Age | 1 | 1989 | 809 | 0.020 |
Why?
|
| Observer Variation | 1 | 1992 | 2605 | 0.020 |
Why?
|
| Polycythemia | 1 | 1986 | 125 | 0.020 |
Why?
|
| Charities | 1 | 2005 | 33 | 0.020 |
Why?
|
| Twins, Conjoined | 1 | 1985 | 41 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 12970 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8529 | 0.020 |
Why?
|
| Macaca mulatta | 3 | 1999 | 2332 | 0.020 |
Why?
|
| Maternal Welfare | 1 | 2005 | 112 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1986 | 246 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2011 | 1071 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1991 | 1793 | 0.010 |
Why?
|
| Europe | 1 | 1991 | 3423 | 0.010 |
Why?
|
| Young Adult | 3 | 2017 | 59207 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5869 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1986 | 255 | 0.010 |
Why?
|
| Speech | 1 | 2008 | 554 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1992 | 2908 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1986 | 542 | 0.010 |
Why?
|
| Needles | 1 | 1986 | 451 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15838 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12720 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11106 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 1990 | 1292 | 0.010 |
Why?
|
| Karyotyping | 3 | 1989 | 1171 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1982 | 207 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 1986 | 596 | 0.010 |
Why?
|
| Amnion | 1 | 1982 | 197 | 0.010 |
Why?
|
| Time Factors | 3 | 1992 | 39975 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2007 | 23990 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 1994 | 15262 | 0.010 |
Why?
|
| Aging | 1 | 1999 | 8705 | 0.010 |
Why?
|
| Polyps | 1 | 2001 | 200 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13255 | 0.010 |
Why?
|
| Prognosis | 3 | 2017 | 29620 | 0.010 |
Why?
|
| Prospective Studies | 3 | 1995 | 54415 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1991 | 1964 | 0.010 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 17644 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2006 | 1815 | 0.010 |
Why?
|
| Heparin | 1 | 1985 | 1632 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1987 | 2419 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1985 | 1141 | 0.010 |
Why?
|
| Emergencies | 1 | 2004 | 1217 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15717 | 0.010 |
Why?
|
| Kidney | 1 | 1993 | 7049 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1993 | 18247 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6532 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7389 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6309 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2001 | 1834 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1986 | 1881 | 0.010 |
Why?
|
| Child | 2 | 2017 | 80162 | 0.010 |
Why?
|
| HIV-1 | 1 | 1993 | 6860 | 0.010 |
Why?
|
| Diabetes Mellitus | 3 | 1989 | 5840 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2008 | 3905 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 483 | 0.010 |
Why?
|
| Methylation | 2 | 1988 | 1083 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1494 | 0.010 |
Why?
|
| Surface-Active Agents | 1 | 1994 | 149 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1995 | 282 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1986 | 3396 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1999 | 783 | 0.010 |
Why?
|
| Professional-Patient Relations | 1 | 1999 | 726 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1987 | 7595 | 0.010 |
Why?
|
| Retroviridae Infections | 1 | 1993 | 147 | 0.010 |
Why?
|
| Disclosure | 1 | 1999 | 748 | 0.010 |
Why?
|
| Fibrin | 1 | 1995 | 507 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 12450 | 0.010 |
Why?
|
| Twins | 1 | 1994 | 340 | 0.010 |
Why?
|
| Echocardiography | 1 | 1985 | 4991 | 0.010 |
Why?
|
| Microtomy | 1 | 1972 | 44 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 1993 | 312 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1985 | 2566 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1074 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1995 | 657 | 0.010 |
Why?
|
| Suction | 1 | 1992 | 266 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 41446 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 790 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 4320 | 0.010 |
Why?
|
| Urinary Diversion | 1 | 1991 | 134 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6343 | 0.010 |
Why?
|
| Succinylcholine | 1 | 1989 | 66 | 0.000 |
Why?
|
| Lymphangioma | 1 | 1989 | 61 | 0.000 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 1988 | 100 | 0.000 |
Why?
|
| Anesthesia, Intravenous | 1 | 1989 | 129 | 0.000 |
Why?
|
| Chorioamnionitis | 1 | 1989 | 156 | 0.000 |
Why?
|
| Hydrops Fetalis | 1 | 1988 | 113 | 0.000 |
Why?
|
| Anesthesia, Inhalation | 1 | 1989 | 220 | 0.000 |
Why?
|
| Hematocrit | 1 | 1988 | 625 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1995 | 4016 | 0.000 |
Why?
|
| ROC Curve | 1 | 1994 | 3580 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1986 | 59 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1986 | 352 | 0.000 |
Why?
|
| Punctures | 1 | 1988 | 366 | 0.000 |
Why?
|
| Macrophages | 2 | 1995 | 5768 | 0.000 |
Why?
|
| Monocytes | 1 | 1995 | 2572 | 0.000 |
Why?
|
| Embryonic and Fetal Development | 1 | 1987 | 420 | 0.000 |
Why?
|
| Kell Blood-Group System | 1 | 1985 | 21 | 0.000 |
Why?
|
| Middle Aged | 2 | 2017 | 220826 | 0.000 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1993 | 1784 | 0.000 |
Why?
|
| Fentanyl | 1 | 1989 | 435 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 398 | 0.000 |
Why?
|
| Isoflurane | 1 | 1989 | 384 | 0.000 |
Why?
|
| Hemoglobin A | 1 | 1985 | 84 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1995 | 4001 | 0.000 |
Why?
|
| Pedigree | 1 | 1993 | 4589 | 0.000 |
Why?
|
| C-Peptide | 1 | 1986 | 440 | 0.000 |
Why?
|
| Diseases in Twins | 1 | 1986 | 447 | 0.000 |
Why?
|
| Sheep | 1 | 1987 | 1440 | 0.000 |
Why?
|
| Spinal Neoplasms | 1 | 1989 | 716 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1995 | 11073 | 0.000 |
Why?
|
| Disease Progression | 1 | 1999 | 13502 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1988 | 2613 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1987 | 1524 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1993 | 3155 | 0.000 |
Why?
|
| Cells, Cultured | 2 | 1987 | 18964 | 0.000 |
Why?
|
| Fetal Growth Retardation | 1 | 1985 | 580 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1994 | 12058 | 0.000 |
Why?
|
| Erythropoietin | 1 | 1985 | 719 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 6374 | 0.000 |
Why?
|
| Abdomen | 1 | 1986 | 1128 | 0.000 |
Why?
|
| Diabetes Complications | 1 | 1986 | 1315 | 0.000 |
Why?
|
| Femur | 1 | 1986 | 1307 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 1993 | 39117 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36423 | 0.000 |
Why?
|
| Cell Division | 1 | 1986 | 4466 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1994 | 8487 | 0.000 |
Why?
|
| Gene Expression Regulation | 2 | 1988 | 11902 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1995 | 10194 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1994 | 22168 | 0.000 |
Why?
|
| Mutation | 1 | 1999 | 30045 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1986 | 20556 | 0.000 |
Why?
|